Psylo & CSIRO: A Partnership To Study Neuroplasticity Of New Psychedelic Compounds
Pre-clinical biotech psychedelics company Psylo has signed an agreement with Australia’s national science agency CSIRO to collaboratively investigate the therapeutic potential of the company’s lead drug candidates.
